BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27556138)

  • 1. Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.
    Tauro M; Laghezza A; Loiodice F; Piemontese L; Caradonna A; Capelli D; Montanari R; Pochetti G; Di Pizio A; Agamennone M; Campestre C; Tortorella P
    J Enzyme Inhib Med Chem; 2016; 31(sup4):25-37. PubMed ID: 27556138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.
    Rahman F; Nguyen TM; Adekoya OA; Campestre C; Tortorella P; Sylte I; Winberg JO
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):819-830. PubMed ID: 33757387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol thioethers with physiologically active fragments: Electrochemistry, antioxidant and cryoprotective activities.
    Smolyaninov IV; Pitikova OV; Korchagina EO; Poddel'sky AI; Fukin GK; Luzhnova SA; Tichkomirov AM; Ponomareva EN; Berberova NT
    Bioorg Chem; 2019 Aug; 89():103003. PubMed ID: 31132599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.
    La Motta C; Sartini S; Mugnaini L; Simorini F; Taliani S; Salerno S; Marini AM; Da Settimo F; Lavecchia A; Novellino E; Cantore M; Failli P; Ciuffi M
    J Med Chem; 2007 Oct; 50(20):4917-27. PubMed ID: 17845019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).
    Yuan H; Lu W; Wang L; Shan L; Li H; Huang J; Sun Q; Zhang W
    Eur J Med Chem; 2013 Apr; 62():148-57. PubMed ID: 23353736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes.
    Choi WY; Lim HW; Lim CJ
    J Pharm Pharmacol; 2013 Feb; 65(2):310-6. PubMed ID: 23278699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.
    Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy.
    Wang ZC; Shen FQ; Yang MR; You LX; Chen LZ; Zhu HL; Lu YD; Kong FL; Wang MH
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3816-3821. PubMed ID: 30342958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative structure-activity relationship study on a series of selective non-zinc binding inhibitors of MMP13.
    Singh P
    Med Chem; 2014 Mar; 10(2):174-88. PubMed ID: 23627272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
    Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
    Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
    Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
    Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
    Agamennone M; Belov DS; Laghezza A; Ivanov VN; Novoselov AM; Andreev IA; Ratmanova NK; Altieri A; Tortorella P; Kurkin AV
    ChemMedChem; 2016 Sep; 11(17):1892-8. PubMed ID: 27418256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of bergenin analogues as mushroom tyrosinase inhibitors.
    Kashima Y; Miyazawa M
    Arch Pharm Res; 2012 Sep; 35(9):1533-41. PubMed ID: 23054709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.
    Cheng XC; Wang RL; Dong ZK; Li J; Li YY; Li RR
    Bioorg Med Chem; 2012 Oct; 20(19):5738-44. PubMed ID: 22967811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site.
    Nara H; Sato K; Naito T; Mototani H; Oki H; Yamamoto Y; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
    Bioorg Med Chem; 2014 Oct; 22(19):5487-505. PubMed ID: 25192810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthalene diols: a new class of antioxidants intramolecular hydrogen bonding in catechols, naphthalene diols, and their aryloxyl radicals.
    Foti MC; Johnson ER; Vinqvist MR; Wright JS; Barclay LR; Ingold KU
    J Org Chem; 2002 Jul; 67(15):5190-6. PubMed ID: 12126405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
    Mendes DE; Wong-On-Wing A; Berkman CE
    J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between stoichiometric and anticatalytic antioxidant properties of benzoic acid analogues: a structure/redox potential relationship study.
    Franck T; Mouithys-Mickalad A; Robert T; Ghitti G; Deby-Dupont G; Neven P; Serteyn D
    Chem Biol Interact; 2013 Nov; 206(2):194-203. PubMed ID: 24060682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.
    Campestre C; Agamennone M; Tortorella P; Preziuso S; Biasone A; Gavuzzo E; Pochetti G; Mazza F; Hiller O; Tschesche H; Consalvi V; Gallina C
    Bioorg Med Chem Lett; 2006 Jan; 16(1):20-4. PubMed ID: 16242329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.